The Technical Analyst
Select Language :
Seelos Therapeutics Inc [SEEL]

Exchange: NASDAQ Sector: Healthcare Industry: Biotechnology

Seelos Therapeutics Inc Price, Forecast, Insider, Ratings, Fundamentals & Signals

Seelos Therapeutics Inc is listed at the  Exchange

-6.15% $0.600

America/New_York / 28 mar 2024 @ 13:48


Seelos Therapeutics Inc: Main Fundamentals PE comparison

FUNDAMENTALS
MarketCap: 8.21 mill
EPS: -7.73
P/E: -0.0800
Earnings Date: May 13, 2024
SharesOutstanding: 13.68 mill
Avg Daily Volume: 0.438 mill
RATING 2024-03-28
B-
Neutral
RATINGS
Rating CashFlow: Strong Buy
Return On Equity: Strong Buy
Return On Asset: Strong Sell
DE: Strong Sell
P/E: Sell
Price To Book: Strong Sell
QUARTER GROWTHS
3/224/221/232/233/234/23
Revenuen/an/an/a
Gr.Profitn/an/a
Ebit
Asset
Debt
PE RATIO: COMPANY / SECTOR
0.00x
Company: PE -0.0800 | sector: PE -3.05
PE RATIO: COMPANY / INDUSTRY
-0.01x
Company: PE -0.0800 | industry: PE 5.88
DISCOUNTED CASH FLOW VALUE
N/A
N/A
Expected Trading Range (DAY)

$ 0.463 - 0.737

( +/- 22.83%)
ATR Model: 14 days

Insider Trading

Date Person Action Amount type
2024-02-29 Golembiewski Michael Joseph Buy 417 Common Stock
2024-01-12 Mehra Raj Buy 70 383 Stock Option (right to buy)
2024-01-12 Golembiewski Michael Joseph Buy 24 537 Stock Option (right to buy)
2024-01-04 Pascoe Richard W Buy 1 666 Stock Option (right to buy)
2024-01-04 Dalesandro Margaret Buy 1 666 Stock Option (right to buy)
INSIDER POWER
100.00
Last 92 transactions
Buy: 14 639 227 | Sell: 4 987 490

Forecast: 15:35 - $0.607

Live Trading Signals (every 1 min)

Forecast 1: 14:05 - $0.607
Forecast 2: 14:55 - $0.617
Forecast 3: 15:35 - $0.607
SCORE
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Indicator Signals
RSI 21
SMA
Trend
Trend 2
Trend 3
MACD
Volume Signals
Price $0.600 (-6.15% )
Volume 0.380 mill
Avg. Vol. 0.438 mill
% of Avg. Vol 86.64 %
Signal 1:
Signal 2:

Today

Intraday chart data with high, low, open and close for Seelos Therapeutics Inc

Last 12 Months

Last 12 months chart data with high, low, open and close for Seelos Therapeutics Inc

RSI

Intraday RSI14 chart for Seelos Therapeutics Inc

Last 10 Buy & Sell Signals For SEEL

0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%

Avg return buy: 0.00 % | Avg return sell: 0.00 %

$1 invested is now $1.00 or 0.00% since Coming Soon

Date Signal @ Closed %
Profile picture for
            Seelos Therapeutics Inc

SEEL

Seelos Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of central nervous system, respiratory, and other disorders. The company's lead programs are SLS-002, an intranasal racemic ketamine for the treatment of acute suicidal ideation and behavior in patients with major depressive disorders; SLS-005, a protein stabilizer for the treatment of amyotrophic lateral sclerosis and Sanfilippo syndrome; and SLS-006, a partial dopamine agonist for the treatment of patients with Parkinson's disease (PD). Its preclinical programs include SLS-007, an anti-alpha-synuclein peptidic inhibitor to treat patients with PD; SLS-008, an orally available antagonist for chemoattractant receptor-homologous molecule for the treatment of chronic inflammation in asthma and pediatric orphan indications; SLS-004 for the treatment of PD; SLS-010, an oral histamine H3A receptor antagonist for narcolepsy and related disorders; and SLS-012, an injectable therapy for post-operative pain management. Seelos Therapeutics, Inc. was incorporated in 1987 and is headquartered in New York, New York.

Last 10 Buy Signals

Date Signal @
UNFIUSDMar 28 - 13:547.44
WOOUSDMar 28 - 13:54$0.455
SFPUSDMar 28 - 13:54$0.777
POLSUSDMar 28 - 13:54$1.220
BARUSDMar 28 - 13:543.65
CREAMUSDMar 28 - 13:5429.76
NTRAMar 28 - 13:54$90.98
CTASMar 28 - 13:54$682.38
NEXOUSDMar 28 - 13:531.331
PAASMar 28 - 13:50$15.06

Latest Press Releases

Latest News

Disclaimer:

"JimStromberg.com" is a research service that provides financial data and technical analysis of publicly traded stocks. All users should speak with their financial advisor before buying or selling any securities. Users should not base their investment decision upon "JimStromberg.com". By using the site you agree and are held liable for your own investment decisions and agree to Terms of Use and Privacy Policy. Please read the full disclaimer here.